Safe Supply Streaming Co. Highlights Amsterdam Mayor’s Recent Call for New Regulation of Narcotics

Toronto, Ontario–(Newsfile Corp. – January 26, 2024) – Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) (“Safe Supply” or “the Company”), the first company investing in and incubating companies at the forefront of the third wave of drug policy reform, would like to share the recent statement from Amsterdam Mayor Femke Halsema whereby she called for the new regulation of the sale and use of narcotics, primarily cocaine, to counteract the economics of illegal enterprises “racking up billions in profit”. The mayor organized a public debate on the subject on January 26.

In an interview to a local newspaper, Femke Halsema said: “Let us conclude that hundreds of years of discouragement and repression have achieved very little. Apparently, people have a need for stimulants. There is a market for that.”

In 2022, Halsema already told Bloomberg that “the war on drugs is only good news for organized crime”. The Netherlands, alongside the rest of Europe, has seen a big increase in cocaine shipments over the past year. In 2023, Dutch customs seized nearly 60 metric tons of cocaine, up from 51 tons in the previous year.

“This development in one of European capitals provides more proof of the narrative we have been communicating to the public,” said Bill Panagiotakopoulos, CEO of Safe Supply. “We are witnessing a big shift in public perception of drug decriminalization, and there are more drug policy reforms to come in the near term. Safe Supply is dedicated to its mission of being at the forefront of a responsible end to the war on drugs, and we look forward to the headway in this field.”

About Safe Supply Streaming

Safe Supply Streaming Co. Ltd. is investing in and incubating companies at the forefront of the third wave of drug policy reform. As jurisdictions around the world move to decriminalize, regulate and legalize drugs, Safe Supply is investing in the infrastructure necessary to support the transition. From developing the facilities to analyze, manufacture and distribute psychoactive compounds including the coca plant, to investing in the research and innovation to harness the potential, and minimize the harm, of these medicines, to constructing the clinical infrastructure to ensure safe and responsible access and treatment, Safe Supply is building a platform of tightly woven companies that will help save millions of lives and build a safer, healthier post-war on drugs worlds.

Learn more at www.safesupply.com and follow Safe Supply on LinkedIn, Twitter, and Instagram.

For Further Information:

Bill Panagiotakopoulos
Chief Executive Officer and Director
Safe Supply Streaming Co. Ltd.
https://safesupply.com/
bill@safesupply.com

Media contacts:
McKenna Miller
KCSA Strategic Communications
safesupply@kcsa.com

Forward-Looking Information and Statements

Certain statements in this news release related to Safe Supply and Origin are forward-looking statements and are prospective in nature, including but not limited to the express or implied statements and assumptions regarding the intention of Origin and Safe Supply to complete the Transaction. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These forward-looking statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “will” or “continue”, or the negative thereof or similar variations. There are numerous risks and uncertainties that could cause actual results and Origin’s and Safe Supply’s plans and objectives to differ materially from those expressed in the forward-looking information, including but not limited to adverse market conditions and risks inherent in Origin’s and Safe Supply’s respective businesses. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this press release. Except as required by applicable law, Origin and Safe Supply do not intend to update these forward-looking statements. Without limiting the generality of the foregoing, there can be no assurance that the Transaction will be completed as proposed, or at all. Investors are cautioned that, except as disclosed in the management information circular and/or listing statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of Origin should be considered highly speculative.

The CSE has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/195743